Answers are grounded in this paper and cite their sources.
Five compounds based on [MnMo(9)O(32)](6-): (Himi)(6)[MnMo(9)O(32)] (1) (imi=imidazole), Na(2)(Himi)(4)[MnMo(9)O(32)]2 H(2)O (2), Na(3)(Himi)(3)[MnMo(9)O(32)] (3), D-NH(4)Mn(2.5)[MnMo(9)O(32)]11 H(2)O (4 a), and L-NH(4)Mn(2.5)[MnMo(9)O(32)]11 H(2)O (4 b) were prepared and characterized. X-ray crystallographic analysis revealed that compounds 1 and 2 with imidazole molecules as linkers are racemic compounds; compound 3 is a racemic solid solution of Na(+) cations and the polyoxoanion [MnMo(9)O(32)](6-); and compounds 4 a and 4 b are enantiomers. In compound 4, the homochiral polyoxoanions [MnMo(9)O(32)](6-) are connected by Mn(2+) cations to form a unique (4(5)6)(4(7)6(8)) topology net framework. By adjusting the linkers from imidazole molecules to Na(+) and finally Mn(2+) cations, the chiral polyoxoanions [MnMo(9)O(32)](6-) were changed from a racemic compound to a conglomerate. This means that spontaneous resolution can be efficiently realized by connecting homochiral polyoxoanions into one-dimensional (1D), 2D, and 3D structures, with an emphasis on using appropriate linkers with substantial interaction strength, directionality, and enantioselectivity.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: